Activation of HIV-1 Gag-specific CD8+ T cells by yeast-derived VLP-pulsed dendritic cells is influenced by the level of mannose on the VLP antigen.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Microbes and infection

• Publication date

  2009-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.micinf.2008.11.004PMID 19059495
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB.

  2007cited by this paper
• C-Type Lectin DC-SIGN Modulates Toll-like Receptor Signaling via Raf-1 Kinase-Dependent Acetylation of Transcription Factor NF-κB

  2007cited by this paper
• HIV vaccines: new frontiers in vaccine development.

  2006cited by this paper
• DC-SIGN ligation on dendritic cells results in ERK and PI3K activation and modulates cytokine production.

  2006cited by this paper
• Dendritic cells as therapeutic vaccines against cancer

  2005cited by this paper
• Therapeutic dendritic-cell vaccine for chronic HIV-1 infection

  2004cited by this paper
• Dendritic cell immunotherapy: mapping the way

  2004cited by this paper
• Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease.

  2003cited by this paper
• Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function

  2003cited by this paper
• Prevention of allograft rejection by in vitro generated tolerogenic dendritic cells.

  2003cited by this paper
• Therapeutic dendritic-cell vaccine for simian AIDS

  2003cited by this paper
• Dendritic cells, new tools for vaccination.

  2003cited by this paper
• Twenty years of therapy for HIV-1 infection

  2003cited by this paper
• Yeast-Derived Human Immunodeficiency Virus Type 1 p55gag Virus-Like Particles Activate Dendritic Cells (DCs) and Induce Perforin Expression in Gag-Specific CD8+ T Cells by Cross-Presentation of DCs

  2003cited by this paper
• HIV type 1 Gag virus-like particle budding from spheroplasts of Saccharomyces cerevisiae

  2002cited by this paper
• An Efficient and Versatile Mammalian Viral Vector System for Major Histocompatibility Complex Class I/Peptide Complexes

  2002cited by this paper
• Dendritic Cell-Based Immunoregulatory Strategies

  2002cited by this paper
• Induction of immune tolerance by dendritic cells: Implications for preventative and therapeutic immunotherapy of autoimmune disease

  2002cited by this paper
• Mannosylated Lipoarabinomannans Inhibit IL-12 Production by Human Dendritic Cells: Evidence for a Negative Signal Delivered Through the Mannose Receptor1

  2001cited by this paper
• Immune control of HIV: the obstacles of HLA and viral diversity

  2001cited by this paper
• Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

  1999cited by this paper
• Dendritic cells and the control of immunity

  1998cited by this paper
• Mannose receptor‐mediated uptake of antigens strongly enhances HLA class II‐restricted antigen presentation by cultured dendritic cells

  1997cited by this paper
• The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells

  1997cited by this paper
• Complete Inhibition of Human Immunodeficiency Virus Gag Myristoylation Is Necessary for Inhibition of Particle Budding (*)

  1996cited by this paper
• Monocyte-derived cultured dendritic cells are susceptible to human immunodeficiency virus infection and transmit virus to resting T cells in the process of nominal antigen presentation

  1995cited by this paper
• Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis

  1991cited by this paper
• Isolation, characterization, and properties of Saccharomyces cerevisiae mnn mutants with nonconditional protein glycosylation defects.

  1990cited by this paper
• Yeast Cell Wall and Cell Surface

  1982cited by this paper

• Yeast-based vaccines: New perspective in vaccine development and application.

  2019cites this paper
• Immunomodulation and Vaccination with RHDV VLP

  2017cites this paper
• Enhancing the functionality of RHDV VLP

  2015influential citation
• Hepatitis C virus--proteins, diagnosis, treatment and new approaches for vaccine development.

  2012cites this paper
• From vaccine practice to vaccine science: the contribution of human immunology to the prevention of infectious disease

  2011cites this paper
• Current World Literature

  2006cites this paper